The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Epogen and Biosimilar Market Research Report 2025

Global Epogen and Biosimilar Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1739060

No of Pages : 73

Ask Your Query

Report Description
Table of Content

Synopsis
EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells.

Global Epogen and Biosimilar market is projected to reach US$ 534.8 million in 2029, increasing from US$ 715 million in 2022, with the CAGR of -3.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Epogen and Biosimilar market research.

Key manufacturers engaged in the Epogen and Biosimilar industry include Amgen and Pfizer etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Epogen and Biosimilar were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Epogen and Biosimilar market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epogen and Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

Amgen
Pfizer

Segment by Type

Brand
Biosimilar

Segment by Application

Hospital
Pharmacy
Other

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Epogen and Biosimilar report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Epogen and Biosimilar Market Overview
1.1 Product Overview and Scope of Epogen and Biosimilar
1.2 Epogen and Biosimilar Segment by Type
1.2.1 Global Epogen and Biosimilar Market Value Comparison by Type (2023-2029)
1.2.2 Brand
1.2.3 Biosimilar
1.3 Epogen and Biosimilar Segment by Application
1.3.1 Global Epogen and Biosimilar Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Epogen and Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Epogen and Biosimilar Revenue 2018-2029
1.4.2 Global Epogen and Biosimilar Sales 2018-2029
1.4.3 Global Epogen and Biosimilar Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Epogen and Biosimilar Market Competition by Manufacturers
2.1 Global Epogen and Biosimilar Sales Market Share by Manufacturers (2018-2023)
2.2 Global Epogen and Biosimilar Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Epogen and Biosimilar Average Price by Manufacturers (2018-2023)
2.4 Global Epogen and Biosimilar Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Epogen and Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epogen and Biosimilar, Product Type & Application
2.7 Epogen and Biosimilar Market Competitive Situation and Trends
2.7.1 Epogen and Biosimilar Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epogen and Biosimilar Players Market Share by Revenue
2.7.3 Global Epogen and Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epogen and Biosimilar Retrospective Market Scenario by Region
3.1 Global Epogen and Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Epogen and Biosimilar Global Epogen and Biosimilar Sales by Region: 2018-2029
3.2.1 Global Epogen and Biosimilar Sales by Region: 2018-2023
3.2.2 Global Epogen and Biosimilar Sales by Region: 2024-2029
3.3 Global Epogen and Biosimilar Global Epogen and Biosimilar Revenue by Region: 2018-2029
3.3.1 Global Epogen and Biosimilar Revenue by Region: 2018-2023
3.3.2 Global Epogen and Biosimilar Revenue by Region: 2024-2029
3.4 North America Epogen and Biosimilar Market Facts & Figures by Country
3.4.1 North America Epogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Epogen and Biosimilar Sales by Country (2018-2029)
3.4.3 North America Epogen and Biosimilar Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Epogen and Biosimilar Market Facts & Figures by Country
3.5.1 Europe Epogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Epogen and Biosimilar Sales by Country (2018-2029)
3.5.3 Europe Epogen and Biosimilar Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epogen and Biosimilar Market Facts & Figures by Country
3.6.1 Asia Pacific Epogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Epogen and Biosimilar Sales by Country (2018-2029)
3.6.3 Asia Pacific Epogen and Biosimilar Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Epogen and Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Epogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Epogen and Biosimilar Sales by Country (2018-2029)
3.7.3 Latin America Epogen and Biosimilar Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Epogen and Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Epogen and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Epogen and Biosimilar Sales by Country (2018-2029)
3.8.3 Middle East and Africa Epogen and Biosimilar Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Epogen and Biosimilar Sales by Type (2018-2029)
4.1.1 Global Epogen and Biosimilar Sales by Type (2018-2023)
4.1.2 Global Epogen and Biosimilar Sales by Type (2024-2029)
4.1.3 Global Epogen and Biosimilar Sales Market Share by Type (2018-2029)
4.2 Global Epogen and Biosimilar Revenue by Type (2018-2029)
4.2.1 Global Epogen and Biosimilar Revenue by Type (2018-2023)
4.2.2 Global Epogen and Biosimilar Revenue by Type (2024-2029)
4.2.3 Global Epogen and Biosimilar Revenue Market Share by Type (2018-2029)
4.3 Global Epogen and Biosimilar Price by Type (2018-2029)
5 Segment by Application
5.1 Global Epogen and Biosimilar Sales by Application (2018-2029)
5.1.1 Global Epogen and Biosimilar Sales by Application (2018-2023)
5.1.2 Global Epogen and Biosimilar Sales by Application (2024-2029)
5.1.3 Global Epogen and Biosimilar Sales Market Share by Application (2018-2029)
5.2 Global Epogen and Biosimilar Revenue by Application (2018-2029)
5.2.1 Global Epogen and Biosimilar Revenue by Application (2018-2023)
5.2.2 Global Epogen and Biosimilar Revenue by Application (2024-2029)
5.2.3 Global Epogen and Biosimilar Revenue Market Share by Application (2018-2029)
5.3 Global Epogen and Biosimilar Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Epogen and Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen Epogen and Biosimilar Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Epogen and Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Epogen and Biosimilar Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epogen and Biosimilar Industry Chain Analysis
7.2 Epogen and Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epogen and Biosimilar Production Mode & Process
7.4 Epogen and Biosimilar Sales and Marketing
7.4.1 Epogen and Biosimilar Sales Channels
7.4.2 Epogen and Biosimilar Distributors
7.5 Epogen and Biosimilar Customers
8 Epogen and Biosimilar Market Dynamics
8.1 Epogen and Biosimilar Industry Trends
8.2 Epogen and Biosimilar Market Drivers
8.3 Epogen and Biosimilar Market Challenges
8.4 Epogen and Biosimilar Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}